Adaptive Physiological Response Systems for Industrial, Transportation, and Recreational Applications

Publication ID: 24-11857758_0007_PTD
Published: November 07, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Adaptive Physiological Response Systems for Industrial, Transportation, and Recreational Applications,” Published Technical Disclosure No. 24-11857758_0007_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857758_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,758.

Summary of the Inventive Concept

This inventive concept leverages the core technology of implantable drug delivery devices to create adaptive systems that monitor and respond to physiological changes in various industries, enhancing performance, safety, and well-being.

Background and Problem Solved

The original patent focused on treating opioid overdoses using implantable drug delivery devices. However, the core technology has broader potential. Industrial, transportation, and recreational industries face challenges related to fatigue, environmental hazards, and performance optimization. The inventive concept addresses these limitations by applying the implantable drug delivery technology to new use cases, enabling real-time monitoring and targeted interventions.

Detailed Description of the Inventive Concept

The new claims introduce implantable sensor devices that detect changes in body temperature, alertness, and other bodily functions. These sensors trigger drug delivery devices to administer stimulants, antidotes, or performance-enhancing substances in response to abnormal physiological responses. In industrial settings, the system prevents fatigue-related accidents. In transportation, it enhances driver alertness. In recreational contexts, it optimizes athletic performance. The wearable device detects environmental hazards and responds with antidotes.

Novelty and Inventive Step

The inventive concept's novelty lies in its application of implantable drug delivery technology to new industries and use cases, going beyond the original patent's focus on opioid overdoses. The inventive step involves integrating sensor devices with drug delivery systems to create adaptive, real-time response mechanisms.

Alternative Embodiments and Variations

Alternative embodiments may include non-implantable sensor devices, wearable patches, or ingestible sensors. Variations could involve different types of stimulants, antidotes, or performance-enhancing substances, as well as adaptations for specific industries or applications.

Potential Commercial Applications and Market

This inventive concept has significant commercial potential in industries such as manufacturing, logistics, transportation, sports, and healthcare. The market for adaptive physiological response systems is vast, with potential applications in worker safety, driver fatigue prevention, athletic performance optimization, and environmental hazard response.

CPC Classifications

SectionClassGroup
A A61 A61M5/14276
A A61 A61B5/4839
A A61 A61B5/4845
A A61 A61B5/4848
A A61 A61K9/0024
A A61 A61K9/0097
A A61 A61M5/44
A A61 A61M31/002
A A61 A61M37/0069
A A61 A61B5/01
A A61 A61F2250/0068
A A61 A61K31/485

Field of Art

Medical device technology, specifically implantable drug delivery systems and physiological monitoring, involving biomedical engineering, sensor technologies, and pharmaceutical delivery mechanisms

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in implantable drug delivery systems, sensor integration, physiological monitoring, and cross-disciplinary medical technology applications

Obviousness Rationale

A person having ordinary skill would recognize that the source patent's implantable drug delivery device provides a foundational technology that can be readily adapted to multiple physiological monitoring and intervention scenarios. The core technological principles of detecting bodily changes and responding with targeted drug delivery are inherently extensible across different industrial, medical, and performance contexts. The PTD's variations represent predictable engineering modifications that leverage the source patent's fundamental technological framework.

Obvious Combinations & Variations

Source Patent Element
Implantable drug delivery device with physiological response detection capabilities
PTD Variation
Expanding detection and response mechanisms to industrial safety, transportation, and athletic performance contexts
Obviousness Reasoning
Known technique of adapting medical technologies to solve problems in adjacent domains, with predictable results of enhanced safety and performance monitoring
Source Patent Element
Temporary seal formed of biocompatible cross-linked polymer
PTD Variation
Utilizing similar biocompatible materials for sensor integration and drug delivery in wearable and implantable devices
Obviousness Reasoning
Predictable materials science approach of leveraging established biocompatible polymers across different medical and industrial device applications
Source Patent Element
Method of delivering drugs in response to physiological reactions
PTD Variation
Extending physiological response detection to broader range of bodily changes including fatigue, environmental exposure, and mental health indicators
Obviousness Reasoning
Finite set of known physiological monitoring techniques applied to create adaptive response systems with expected technological outcomes
Source Patent Element
Drug delivery for treating specific physiological conditions
PTD Variation
Expanding drug delivery to include stimulants, performance enhancers, and industry-specific intervention substances
Obviousness Reasoning
Design choice involving known pharmacological principles of targeted substance delivery based on physiological state
Source Patent Element
Implantable device with temperature and bodily function monitoring
PTD Variation
Integrating sensor technologies to create multi-purpose adaptive response systems across different application domains
Obviousness Reasoning
Predictable engineering solution of generalizing specialized medical monitoring technologies for broader technological applications
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in this Published Technical Disclosure would have been obvious to a person having ordinary skill in the art at the time of invention, as they represent predictable extensions of the technological framework established in US Patent 11857758, involving known techniques of sensor integration, physiological monitoring, and adaptive drug delivery systems across multiple technological domains.

Original Patent Information

Patent NumberUS 11,857,758
TitleDrug delivery device and method
Assignee(s)Purdue Research Foundation